Alembic Limited reported a net profit of Rs 42 crore for the quarter ended December 31, 2007, a jump of 67% as against Rs 25 crore posted in the same period of last fiscal. This includes Profit on sale of surplus land amounting to Rs. 22.55 crore.

Sales for the third quarter stood at Rs 265 crore, a growth of 39 % as compared to Rs 191 crore in the third quarter of the corresponding previous year. Earnings per Share (EPS) for Q3 FY – 08 worked out to Rs 3.04 as compared to Rs 1.81 in Q3 FY – 07.

Sales for the nine months ended December 31, 2007 grew by 37 % to Rs 759 crore compared to Rs 552 crore in the year-ago period, while net profit for the nine-months period to December 31, 2007 rose by 62% to Rs 97 crore, as against Rs 60 crore posted in same period of last fiscal.

The Company’s sales to regulated markets in the quarter was significantly higher at Rs. 59 crore against Rs. 11 crore in corresponding quarter for the previous year.

The Company’s API facility was successfully re-inspected by USFDA. The Company’s formulation facility at Panelav also got successfully inspected by USFDA.With effect from 1st January, 2008 Alembic has acquired API manufacturing unit for its regulatory fillings for a consideration of Rs. 17.50 crore.

Sourced From: Adfactors Public Relations Pvt Ltd

Tags: calls, daytrading, free calls, intraday, tips

Similar Posts:

• Alembic’s revenues up 42% at Rs 1027cr
• Granules India Q2FY08 net sales up 5.44% at Rs 53cr
• Sanghvi Movers Q3FY08 net profit up 111% at Rs 17.76cr
• Alembic eyeing for Rs 2000cr revenues in 4 years
• Everest Kanto Q3FY08 net profit at Rs 29.42cr up 44%